Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC4 APPBP2 ERCC3 DDX12P DNAH10 VWA8 MYO9A DNAH2 PSMC1 ATAD2 KIF20B LONP1 MYH14 SMARCA4 ABCC12 DNAH9	1.14e-07	614	104	16	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC4 ERCC3 DDX12P DNAH10 VWA8 DNAH2 PSMC1 ATAD2 KIF20B LONP1 SMARCA4 ABCC12 DNAH9	4.92e-07	441	104	13	GO:0016887
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	GTPBP4 ABCC4 ERCC3 DDX12P DNAH10 VWA8 DNAH2 PSMC1 ATAD2 KIF20B SEPTIN6 LONP1 SMARCA4 SEPTIN11 ABCC12 DNAH9	2.48e-06	775	104	16	GO:0017111
GeneOntologyMolecularFunction	cytoskeletal motor activity	APPBP2 DNAH10 MYO9A DNAH2 KIF20B MYH14 DNAH9	2.78e-06	118	104	7	GO:0003774
GeneOntologyMolecularFunction	pyrophosphatase activity	GTPBP4 ABCC4 ERCC3 DDX12P DNAH10 VWA8 DNAH2 PSMC1 ATAD2 KIF20B SEPTIN6 LONP1 SMARCA4 SEPTIN11 ABCC12 DNAH9	6.81e-06	839	104	16	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	GTPBP4 ABCC4 ERCC3 DDX12P DNAH10 VWA8 DNAH2 PSMC1 ATAD2 KIF20B SEPTIN6 LONP1 SMARCA4 SEPTIN11 ABCC12 DNAH9	6.91e-06	840	104	16	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	GTPBP4 ABCC4 ERCC3 DDX12P DNAH10 VWA8 DNAH2 PSMC1 ATAD2 KIF20B SEPTIN6 LONP1 SMARCA4 SEPTIN11 ABCC12 DNAH9	6.91e-06	840	104	16	GO:0016818
GeneOntologyMolecularFunction	microtubule motor activity	APPBP2 DNAH10 DNAH2 KIF20B DNAH9	3.22e-05	70	104	5	GO:0003777
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH2 DNAH9	1.06e-04	18	104	3	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DNAH2 DNAH9	4.09e-04	28	104	3	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH10 DNAH2 DNAH9	9.38e-04	37	104	3	GO:0045505
GeneOntologyBiologicalProcess	gliogenesis	PENK SRGAP2 NR3C1 ADAM22 SRGAP2C ARRB2 PPP3R1 NF2 TTC21B SMARCA4 PLEC CNP	2.21e-06	435	105	12	GO:0042063
GeneOntologyBiologicalProcess	transcription initiation-coupled chromatin remodeling	SETD1A NR3C1 ATAD2 SMARCA4 TET3	2.01e-05	65	105	5	GO:0045815
GeneOntologyBiologicalProcess	positive regulation of gene expression, epigenetic	SETD1A NR3C1 ATAD2 SMARCA4 TET3	2.51e-05	68	105	5	GO:0141137
GeneOntologyBiologicalProcess	extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration	SRGAP2 SRGAP2C	2.57e-05	2	105	2	GO:0021816
GeneOntologyCellularComponent	microtubule	APPBP2 DNAH10 POLB DNAH2 ARFGEF2 KIF20B MISP DNAH9 FKBP4 CNP TBCA DYNC1LI2	1.67e-05	533	106	12	GO:0005874
GeneOntologyCellularComponent	symmetric synapse	PENK ARFGEF2 SEPTIN11	3.49e-05	13	106	3	GO:0032280
GeneOntologyCellularComponent	axon	PDE2A MYO9A PENK CPLX1 SMURF1 GRIA1 ADAM22 KIF20B ADCY9 SEPTIN6 MYH14 SPHK1 SEPTIN11 PLEC FKBP4	4.29e-05	891	106	15	GO:0030424
GeneOntologyCellularComponent	glutamatergic synapse	MYO9A CPLX1 ARFGEF2 GRIA1 SRGAP2 NR3C1 CBLB ADAM22 SRGAP2C ARRB2 PPP3R1 SEPTIN11 SRGAP2B GSG1L	6.54e-05	817	106	14	GO:0098978
GeneOntologyCellularComponent	dynein complex	DNAH10 DNAH2 DNAH9 DYNC1LI2	1.63e-04	54	106	4	GO:0030286
GeneOntologyCellularComponent	microtubule associated complex	APPBP2 DNAH10 DNAH2 KIF20B DNAH9 DYNC1LI2	1.72e-04	161	106	6	GO:0005875
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	APPBP2 DNAH10 MYO9A POLB DNAH2 ARFGEF2 KIF20B MISP PLEC DNAH9 FKBP4 CNP TBCA DYNC1LI2	1.79e-04	899	106	14	GO:0099513
GeneOntologyCellularComponent	axonemal dynein complex	DNAH10 DNAH2 DNAH9	2.69e-04	25	106	3	GO:0005858
GeneOntologyCellularComponent	supramolecular fiber	APPBP2 DNAH10 MYO9A POLB DNAH2 ARFGEF2 NEB KIF20B MISP MYH14 PLEC DNAH9 FKBP4 CNP TBCA DYNC1LI2	2.88e-04	1179	106	16	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	APPBP2 DNAH10 MYO9A POLB DNAH2 ARFGEF2 NEB KIF20B MISP MYH14 PLEC DNAH9 FKBP4 CNP TBCA DYNC1LI2	3.10e-04	1187	106	16	GO:0099081
GeneOntologyCellularComponent	neuron to neuron synapse	PENK ARFGEF2 GRIA1 SRGAP2 NR3C1 DNAJC6 ADAM22 PPP3R1 SEPTIN11 GSG1L	3.28e-04	523	106	10	GO:0098984
GeneOntologyCellularComponent	inner dynein arm	DNAH10 DNAH2	1.12e-03	10	106	2	GO:0036156
GeneOntologyCellularComponent	dendrite	PDE2A PENK CPLX1 ARFGEF2 GRIA1 SRGAP2 NR3C1 ADA ADCY9 ARRB2 SEPTIN11 PLEC	1.35e-03	858	106	12	GO:0030425
GeneOntologyCellularComponent	9+2 motile cilium	DNAH10 DNAH2 SEPTIN6 CFAP57 DNAH9 IQCG	1.35e-03	238	106	6	GO:0097729
GeneOntologyCellularComponent	dendritic tree	PDE2A PENK CPLX1 ARFGEF2 GRIA1 SRGAP2 NR3C1 ADA ADCY9 ARRB2 SEPTIN11 PLEC	1.38e-03	860	106	12	GO:0097447
GeneOntologyCellularComponent	dendritic spine	ARFGEF2 GRIA1 SRGAP2 NR3C1 ARRB2 SEPTIN11	1.47e-03	242	106	6	GO:0043197
GeneOntologyCellularComponent	neuron spine	ARFGEF2 GRIA1 SRGAP2 NR3C1 ARRB2 SEPTIN11	1.63e-03	247	106	6	GO:0044309
GeneOntologyCellularComponent	postsynapse	MYO9A CPLX1 ARFGEF2 GRIA1 SRGAP2 NR3C1 CBLB DNAJC6 ADAM22 ARRB2 PPP3R1 SEPTIN11 GSG1L	1.92e-03	1018	106	13	GO:0098794
GeneOntologyCellularComponent	cilium	ARL2BP ABCC4 DNAH10 DNAH2 ARFGEF2 SEPTIN6 NPHP3 TBC1D31 TTC21B CFAP57 DNAH9 IQCG	1.98e-03	898	106	12	GO:0005929
GeneOntologyCellularComponent	septin complex	SEPTIN6 SEPTIN11	2.23e-03	14	106	2	GO:0031105
GeneOntologyCellularComponent	septin ring	SEPTIN6 SEPTIN11	2.23e-03	14	106	2	GO:0005940
GeneOntologyCellularComponent	actin cytoskeleton	CDC42BPA MYO9A NEB CDC42BPB MISP NF2 MYH14 SEPTIN11 IQCG	2.64e-03	576	106	9	GO:0015629
GeneOntologyCellularComponent	spindle	ARL2BP DDX12P POLB NR3C1 CHAMP1 KIF20B SEPTIN6 MISP	2.75e-03	471	106	8	GO:0005819
GeneOntologyCellularComponent	septin cytoskeleton	SEPTIN6 SEPTIN11	2.92e-03	16	106	2	GO:0032156
GeneOntologyCellularComponent	actomyosin	CDC42BPA CDC42BPB MYH14 SEPTIN11	2.99e-03	117	106	4	GO:0042641
Domain	P-loop_NTPase	GTPBP4 ABCC4 ERCC3 DNAH10 VWA8 MYO9A DNAH2 PSMC1 ATAD2 KIF20B SEPTIN6 LONP1 NPHP3 MYH14 SMARCA4 SEPTIN11 CARD11 ABCC12 DNAH9 CNP DYNC1LI2	5.88e-09	848	103	21	IPR027417
Domain	AAA	ABCC4 DNAH10 VWA8 DNAH2 PSMC1 ATAD2 LONP1 ABCC12 DNAH9	1.02e-07	144	103	9	SM00382
Domain	AAA+_ATPase	ABCC4 DNAH10 VWA8 DNAH2 PSMC1 ATAD2 LONP1 ABCC12 DNAH9	1.02e-07	144	103	9	IPR003593
Domain	-	GTPBP4 ABCC4 ERCC3 DNAH10 VWA8 DNAH2 PSMC1 ATAD2 SEPTIN6 LONP1 NPHP3 SMARCA4 SEPTIN11 CARD11 ABCC12 DNAH9 CNP DYNC1LI2	1.24e-07	746	103	18	3.40.50.300
Domain	srGAP2	SRGAP2 SRGAP2C SRGAP2B	1.63e-07	3	103	3	IPR030252
Domain	ATPase_dyneun-rel_AAA	DNAH10 VWA8 DNAH2 DNAH9	8.37e-07	14	103	4	IPR011704
Domain	AAA_5	DNAH10 VWA8 DNAH2 DNAH9	8.37e-07	14	103	4	PF07728
Domain	DHC_N1	DNAH10 DNAH2 DNAH9	8.94e-06	8	103	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DNAH2 DNAH9	8.94e-06	8	103	3	IPR013594
Domain	KELK	CDC42BPA CDC42BPB	3.01e-05	2	103	2	IPR031597
Domain	KELK	CDC42BPA CDC42BPB	3.01e-05	2	103	2	PF15796
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	PF08393
Domain	MT	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	PF12777
Domain	AAA_8	DNAH10 DNAH2 DNAH9	5.67e-05	14	103	3	PF12780
Domain	DHC_fam	DNAH10 DNAH2 DNAH9	7.06e-05	15	103	3	IPR026983
Domain	Dynein_heavy	DNAH10 DNAH2 DNAH9	7.06e-05	15	103	3	PF03028
Domain	Dynein_heavy_dom	DNAH10 DNAH2 DNAH9	7.06e-05	15	103	3	IPR004273
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPA CDC42BPB	1.79e-04	4	103	2	IPR014930
Domain	DCB_dom	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	IPR032629
Domain	Sec7_C	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	IPR015403
Domain	DUF1981	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	PF09324
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPA CDC42BPB	1.79e-04	4	103	2	PD011252
Domain	Sec7_N	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	IPR032691
Domain	Sec7_N	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	PF12783
Domain	DCB	ARFGEF2 ARFGEF1	1.79e-04	4	103	2	PF16213
Domain	DMPK_coil	CDC42BPA CDC42BPB	1.79e-04	4	103	2	PF08826
Domain	FCH	SRGAP2 SRGAP2C SRGAP2B	2.32e-04	22	103	3	PF00611
Domain	FCH	SRGAP2 SRGAP2C SRGAP2B	2.32e-04	22	103	3	SM00055
Domain	FCH_dom	SRGAP2 SRGAP2C SRGAP2B	2.66e-04	23	103	3	IPR001060
Domain	TPR_REGION	APPBP2 DNAH10 DNAH2 NPHP3 TTC21B FKBP4	3.06e-04	165	103	6	PS50293
Domain	TPR	APPBP2 DNAH10 DNAH2 NPHP3 TTC21B FKBP4	3.06e-04	165	103	6	PS50005
Domain	F_BAR	SRGAP2 SRGAP2C SRGAP2B	3.43e-04	25	103	3	IPR031160
Domain	F_BAR	SRGAP2 SRGAP2C SRGAP2B	3.43e-04	25	103	3	PS51741
Domain	ZF_DAG_PE_1	CDC42BPA MYO9A KSR2 CDC42BPB	4.30e-04	64	103	4	PS00479
Domain	ZF_DAG_PE_2	CDC42BPA MYO9A KSR2 CDC42BPB	4.30e-04	64	103	4	PS50081
Domain	C1	CDC42BPA MYO9A KSR2 CDC42BPB	4.56e-04	65	103	4	SM00109
Domain	PE/DAG-bd	CDC42BPA MYO9A KSR2 CDC42BPB	4.84e-04	66	103	4	IPR002219
Domain	AAA	VWA8 PSMC1 ATAD2	8.61e-04	34	103	3	PS00674
Domain	G_SEPTIN_dom	SEPTIN6 SEPTIN11	2.26e-03	13	103	2	IPR030379
Domain	Septin	SEPTIN6 SEPTIN11	2.26e-03	13	103	2	PF00735
Domain	G_SEPTIN	SEPTIN6 SEPTIN11	2.26e-03	13	103	2	PS51719
Domain	Septin	SEPTIN6 SEPTIN11	2.62e-03	14	103	2	IPR016491
Domain	CNH	CDC42BPA CDC42BPB	2.62e-03	14	103	2	SM00036
Domain	AAA	PSMC1 ATAD2 LONP1	2.96e-03	52	103	3	PF00004
Domain	-	ARFGEF2 ARFGEF1	3.02e-03	15	103	2	1.10.1000.11
Domain	CNH	CDC42BPA CDC42BPB	3.02e-03	15	103	2	PF00780
Domain	Sec7	ARFGEF2 ARFGEF1	3.02e-03	15	103	2	PF01369
Domain	CNH	CDC42BPA CDC42BPB	3.02e-03	15	103	2	PS50219
Domain	CNH_dom	CDC42BPA CDC42BPB	3.02e-03	15	103	2	IPR001180
Domain	Sec7_alpha_orthog	ARFGEF2 ARFGEF1	3.02e-03	15	103	2	IPR023394
Domain	ATPase_AAA_core	PSMC1 ATAD2 LONP1	3.29e-03	54	103	3	IPR003959
Domain	SEC7	ARFGEF2 ARFGEF1	3.44e-03	16	103	2	PS50190
Domain	Sec7	ARFGEF2 ARFGEF1	3.44e-03	16	103	2	SM00222
Domain	Sec7_dom	ARFGEF2 ARFGEF1	3.44e-03	16	103	2	IPR000904
Domain	PBD	CDC42BPA CDC42BPB	3.44e-03	16	103	2	SM00285
Domain	C1_1	CDC42BPA KSR2 CDC42BPB	3.84e-03	57	103	3	PF00130
Domain	CRIB	CDC42BPA CDC42BPB	5.36e-03	20	103	2	PS50108
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ABCC4 FOXK2 CDC42BPA MYO9A CDK19 KSR2 PRR5 SMURF1 SRGAP2 CDC42BPB SEPTIN6 MICU1 ARRB2 NF2 MYH14 TTC21B SEPTIN11 ARIH1 PRORP POLK TET3	3.90e-09	1489	106	21	28611215
Pubmed	Inhibition of SRGAP2 function by its human-specific paralogs induces neoteny during spine maturation.	SRGAP2 SRGAP2C SRGAP2B	2.75e-08	3	106	3	22559944
Pubmed	Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication.	SRGAP2 SRGAP2C SRGAP2B	1.10e-07	4	106	3	22559943
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A PDE2A FOXK2 CDC42BPA KIAA0513 SZT2 VWA8 KSR2 ARFGEF2 SRGAP2 CDC42BPB ADCY9 NF2 SPHK1 CSAD PLEC	2.45e-07	1105	106	16	35748872
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	GTPBP4 VWA8 PSMC1 NCBP1 TACC2 SRGAP2 SSRP1 CHAMP1 LONP1 PPP2R5D ARRB2 MIA2 CTNNBL1 SMARCA4 PLEC NONO CNP XPOT	2.70e-07	1415	106	18	28515276
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PDE2A MYO9A SMURF1 PSMC1 ARFGEF2 GRIA1 SRGAP2 DNAJC6 CDC42BPB ADAM22 SEPTIN6 MISP LONP1 MYH14 SMARCA4 SEPTIN11 PLEC CNP	3.19e-07	1431	106	18	37142655
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A GNPTAB PSMC1 ARFGEF2 NCBP1 SRGAP2 CDC42BPB ADAM22 HMG20A MICU1 MIA2 PPP3R1 NF2 MYH14 SMARCA4 PLEC XPOT	3.51e-07	1285	106	17	35914814
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CDC42BPA KIAA0513 VWA8 CPLX1 PSMC1 GRIA1 TACC2 CDC42BPB ADAM22 SEPTIN6 MICU1 LONP1 PPP2R5D PPP3R1 SEPTIN11 PLEC	3.66e-07	1139	106	16	36417873
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GTPBP4 SETD1A ERCC3 MYO9A PSMC1 SSRP1 ATAD2 KIF20B LONP1 ARRB2 MYH14 CTNNBL1 SMARCA4 PLEC NONO CNP XPOT	7.17e-07	1353	106	17	29467282
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	GTPBP4 ERCC3 POLB NCBP1 SRGAP2 MISP ARRB2 NF2 CTNNBL1 PLEC NONO CNP	8.57e-07	660	106	12	32780723
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SETD1A NCBP1 SSRP1 CHAMP1 CDC42BPB MYH14 CTNNBL1 SMARCA4	1.08e-06	251	106	8	31076518
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	GTPBP4 DNAH2 PSMC1 SSRP1 SEPTIN6 MYH14 SMARCA4 SEPTIN11 PLEC NONO FKBP4 TBCA DYNC1LI2	1.92e-06	847	106	13	35235311
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	GTPBP4 SSRP1 CDC42BPB HMG20A LONP1 MYH14 SMARCA4 PLEC ARIH1 CNP XPOT	2.37e-06	601	106	11	33658012
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	LRRC57 CDC42BPA SRGAP2 CDC42BPB ADCY9 C1orf21 NF2 SEPTIN11 CNP	2.45e-06	377	106	9	38117590
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC3 FOXK2 CDC42BPA PSMC1 DNAJC21 SRGAP2 SSRP1 ATAD2 CDC42BPB KIF20B HMG20A MICU1 C1orf21 CTNNBL1 SEPTIN11 NONO CNP	2.83e-06	1497	106	17	31527615
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	SETD1A PSMC1 ARFGEF2 ARFGEF1 KIF20B MYH14 SMARCA4 PLEC ARIH1 FKBP4	2.88e-06	494	106	10	26831064
Pubmed	DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2.	GTPBP4 NCBP1 MISP PLEC NONO	3.05e-06	73	106	5	35973989
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	GTPBP4 ERCC3 FOXK2 CDC42BPA VWA8 NCBP1 SSRP1 CDC42BPB SEPTIN6 MYH14 CTNNBL1 SMARCA4 FTL PLEC NONO CNP	4.06e-06	1371	106	16	36244648
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	GTPBP4 PSMC1 NCBP1 SSRP1 LONP1 SMARCA4 PLEC NONO FKBP4 CNP XPOT	4.18e-06	638	106	11	33239621
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	GTPBP4 ERCC3 CDC42BPA VWA8 SMURF1 NCBP1 SSRP1 CHAMP1 HMG20A CTNNBL1 SMARCA4 PLEC NONO DYNC1LI2	5.41e-06	1082	106	14	38697112
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FOXK2 SLC7A13 SMURF1 TACC2 SRGAP2 SEPTIN6 NPHP3 TBC1D31 NF2 SEPTIN11 PLEC POLK DYNC1LI2 XPOT	5.53e-06	1084	106	14	11544199
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	PSMC1 DNAJC21 ADCY9 SMARCA4 ARIH1 FKBP4 CCDC70	6.12e-06	225	106	7	25277244
Pubmed	Chromatin remodeling during glucocorticoid receptor regulated transactivation.	NR3C1 SMARCA4	9.20e-06	2	106	2	22425674
Pubmed	Cloning and chromosomal localization of human Cdc42-binding protein kinase beta.	CDC42BPA CDC42BPB	9.20e-06	2	106	2	10198171
Pubmed	SRGAP2 and Its Human-Specific Paralog Co-Regulate the Development of Excitatory and Inhibitory Synapses.	SRGAP2 SRGAP2C	9.20e-06	2	106	2	27373832
Pubmed	Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	23918382
Pubmed	Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	17360629
Pubmed	Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	10716990
Pubmed	Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.	CDC42BPA CDC42BPB	9.20e-06	2	106	2	18263588
Pubmed	Membrane association of the Arabidopsis ARF exchange factor GNOM involves interaction of conserved domains.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	18203920
Pubmed	Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.	NR3C1 FKBP4	9.20e-06	2	106	2	19073255
Pubmed	Overexpression, characterization, and purification of a recombinant mouse immunophilin FKBP-52 and identification of an associated phosphoprotein.	NR3C1 FKBP4	9.20e-06	2	106	2	8341706
Pubmed	Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	18417613
Pubmed	The human-specific paralogs SRGAP2B and SRGAP2C differentially modulate SRGAP2A-dependent synaptic development.	SRGAP2C SRGAP2B	9.20e-06	2	106	2	31822692
Pubmed	Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate-like invariant T lymphocytes.	NR3C1 ARRB2	9.20e-06	2	106	2	31108170
Pubmed	Interaction of the glucocorticoid receptor with the chromatin landscape.	NR3C1 SMARCA4	9.20e-06	2	106	2	18342607
Pubmed	3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.	NR3C1 FKBP4	9.20e-06	2	106	2	15159550
Pubmed	Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.	NR3C1 FKBP4	9.20e-06	2	106	2	11278753
Pubmed	Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	9.20e-06	2	106	2	10212200
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	LRRC57 CDC42BPA ARFGEF2 ARFGEF1 ATAD2 CDC42BPB ADCY9 C1orf21 NF2 IQCG	9.92e-06	569	106	10	30639242
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	SEPTIN6 LONP1 PHF20L1 SEPTIN11 CNP DYNC1LI2	1.12e-05	163	106	6	16512683
Pubmed	Defining the membrane proteome of NK cells.	GTPBP4 ABCC4 PSMC1 ARFGEF2 LONP1 MIA2 NF2 MYH14 CTNNBL1 SMARCA4 FTL NONO CNP DYNC1LI2	1.28e-05	1168	106	14	19946888
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	DNAH2 NEB DNAH9 DYNC1LI2	1.31e-05	47	106	4	8812413
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	GTPBP4 ERCC3 FOXK2 NCBP1 SSRP1 CHAMP1 HMG20A LONP1 CTNNBL1 SMARCA4 PLEC ARIH1 FKBP4	1.33e-05	1014	106	13	32416067
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	SETD1A CDC42BPA DNAH10 DNAH2 SMURF1 CDC42BPB ADAMTS12 SMARCA4 PLCB2 ARIH1 NONO	1.48e-05	730	106	11	34857952
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	PSMC1 ARFGEF1 NCBP1 NR3C1 SSRP1 CHAMP1 MISP CTNNBL1 SEPTIN11 NUDCD1 ARIH1 NONO FKBP4 CNP TBCA	1.73e-05	1367	106	15	32687490
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	GTPBP4 FOXK2 NCBP1 SSRP1 ATAD2 CHAMP1 KIF20B HMG20A PHF20L1 SMARCA4	1.75e-05	608	106	10	36089195
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	ERCC3 FOXK2 SSRP1 CHAMP1 SMARCA4 CNP	1.84e-05	178	106	6	27637333
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	POLB CHAMP1 CDC42BPB CTNNBL1 SEPTIN11 NONO FKBP4 CNP DYNC1LI2	2.26e-05	498	106	9	36634849
Pubmed	Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.	NEB CDC42BPB MYH14 PLEC	2.29e-05	54	106	4	22266860
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	ARFGEF2 ARFGEF1 DNAJC6 SMARCA4 FKBP4 DYNC1LI2	2.36e-05	186	106	6	33637726
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	CDC42BPA SZT2 SRGAP2 DNAJC6	2.65e-05	56	106	4	9455484
Pubmed	Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.	SSRP1 SMARCA4	2.76e-05	3	106	2	26842758
Pubmed	SAF-A forms a complex with BRG1 and both components are required for RNA polymerase II mediated transcription.	POLB SMARCA4	2.76e-05	3	106	2	22162999
Pubmed	Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	19332778
Pubmed	Specific functions of BIG1 and BIG2 in endomembrane organization.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	20360857
Pubmed	AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	16866877
Pubmed	MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.	NR3C1 PPP2R5D	2.76e-05	3	106	2	25772595
Pubmed	SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis.	SPHK1 NONO	2.76e-05	3	106	2	34549307
Pubmed	Role of the Ada adaptor complex in gene activation by the glucocorticoid receptor.	NR3C1 ADA	2.76e-05	3	106	2	9154805
Pubmed	Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	31199673
Pubmed	Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1.	NR3C1 SPHK1	2.76e-05	3	106	2	26183376
Pubmed	Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	27162341
Pubmed	The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	23386609
Pubmed	Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).	CBLB NONO	2.76e-05	3	106	2	26342078
Pubmed	Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain.	NR3C1 SMARCA4	2.76e-05	3	106	2	10688647
Pubmed	Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.	NR3C1 FKBP4	2.76e-05	3	106	2	19545546
Pubmed	A C-terminal sequence in the guanine nucleotide exchange factor Sec7 mediates Golgi association and interaction with the Rsp5 ubiquitin ligase.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	18832381
Pubmed	FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.	NR3C1 FKBP4	2.76e-05	3	106	2	15591061
Pubmed	Calcineurin mediates homeostatic synaptic plasticity by regulating retinoic acid synthesis.	GRIA1 PPP3R1	2.76e-05	3	106	2	26443861
Pubmed	Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity.	ADA SPHK1	2.76e-05	3	106	2	25587035
Pubmed	The glucocorticoid receptor recruits the COMPASS complex to regulate inflammatory transcription at macrophage enhancers.	SETD1A NR3C1	2.76e-05	3	106	2	33567280
Pubmed	Distinct functions for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 and BIGs are required for assembly and maintenance of the Golgi stack and trans-Golgi network, respectively.	ARFGEF2 ARFGEF1	2.76e-05	3	106	2	18003980
Pubmed	Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.	GTPBP4 NF2	2.76e-05	3	106	2	17210637
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	GTPBP4 ERCC3 PSMC1 DNAJC21 NCBP1 SSRP1 KIF20B MICU1 MISP SMARCA4 PLEC NONO FKBP4 CNP	2.88e-05	1257	106	14	36526897
Pubmed	Human transcription factor protein interaction networks.	GTPBP4 SETD1A FOXK2 CDC42BPA DNAH10 PSMC1 SEPTIN6 HMG20A LONP1 MYH14 ACTR6 SMARCA4 FTL FKBP4 XPOT	2.89e-05	1429	106	15	35140242
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ERCC3 POLB NCBP1 ATAD2 ARRB2 TBC1D31 MYH14 ACTR6 ZMAT2 CNP	2.90e-05	645	106	10	25281560
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CPLX1 DNAH2 DNAJC21 GRIA1 NCBP1 SSRP1 NEB ADAMTS12 TBC1D31 MIA2 PHF20L1 MYH14 ZMAT2 PLEC NONO	3.21e-05	1442	106	15	35575683
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PSMC1 ARFGEF2 NCBP1 NR3C1 SSRP1 PPP2R5D MYH14 SEPTIN11 FTL NUDCD1 PLEC ARIH1 FKBP4 DYNC1LI2 XPOT	3.55e-05	1455	106	15	22863883
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GTPBP4 PDE2A KSR2 GRIA1 SRGAP2 DNAJC6 CDC42BPB ADAM22 PPP2R5D SMARCA4 SEPTIN11 CNP	3.84e-05	963	106	12	28671696
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	GTPBP4 SETD1A ERCC3 CHAMP1 KIF20B LONP1 MYH14 CTNNBL1	3.84e-05	410	106	8	26949251
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	ABCC4 APPBP2 POLB GNPTAB PENK NEB ATAD2 BCAS4 DNAJC6 SPHK1 ZMAT2 PLEC PRORP CCDC70	3.91e-05	1293	106	14	15342556
Pubmed	Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.	ARL2BP ERCC3 POLB PSMC1 CBLB SEPTIN6 HMG20A ADAMTS12 ARRB2 SYTL5 ZMAT2 TRIM17 CTNNBL1 FTL CCDC70	4.22e-05	1477	106	15	31515488
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	GTPBP4 CDC42BPA VWA8 DNAJC21 NR3C1 SSRP1 ADA DNAJC6 CDC42BPB ADCY9 MICU1 PPP2R5D TBC1D31 NF2 FKBP4	4.55e-05	1487	106	15	33957083
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PRR5 SRGAP2 CBLB ADCY9 ARRB2 C1orf21 NF2 CNP	4.63e-05	421	106	8	36976175
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	SLC7A13 POLB GRIA1 ATAD2 MICU1 NPHP3 C1orf21 MIA2 PHF20L1 TET3	4.86e-05	686	106	10	29987050
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ARL2BP FOXK2 SRGAP2 SSRP1 HMG20A MICU1 LONP1 NPHP3 PPP2R5D TTC21B SEPTIN11 PLEC CNP DYNC1LI2	4.93e-05	1321	106	14	27173435
Pubmed	A new in vivo cross-linking mass spectrometry platform to define protein-protein interactions in living cells.	PSMC1 SEPTIN11 PLEC NONO	5.39e-05	67	106	4	25253489
Pubmed	Human NB-2 of the contactin subgroup molecules: chromosomal localization of the gene (CNTN5) and distinct expression pattern from other subgroup members.	ARFGEF2 ARFGEF1	5.50e-05	4	106	2	11013081
Pubmed	Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.	NR3C1 FKBP4	5.50e-05	4	106	2	25132599
Pubmed	Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.	ARFGEF2 ARFGEF1	5.50e-05	4	106	2	12606707
Pubmed	Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).	ARFGEF2 ARFGEF1	5.50e-05	4	106	2	12571360
Pubmed	BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity.	MYO9A ARFGEF1	5.50e-05	4	106	2	15644318
Pubmed	Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1.	CBLB CARD11	5.50e-05	4	106	2	19815501
Pubmed	Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.	ARFGEF2 ARFGEF1	5.50e-05	4	106	2	22084092
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH10 DNAH9	5.50e-05	4	106	2	11175280
Pubmed	GSG1L suppresses AMPA receptor-mediated synaptic transmission and uniquely modulates AMPA receptor kinetics in hippocampal neurons.	GRIA1 GSG1L	5.50e-05	4	106	2	26932439
Pubmed	A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow.	CDC42BPA CDC42BPB	5.50e-05	4	106	2	18854160
Pubmed	Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.	NR3C1 SMARCA4	5.50e-05	4	106	2	17387179
Pubmed	Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization.	CDC42BPA CDC42BPB	5.50e-05	4	106	2	9418861
Interaction	DPY30 interactions	SETD1A FOXK2 CPLX1 PSMC1 ARFGEF2 ARFGEF1 NR3C1 SSRP1 BCAS4	1.32e-06	204	106	9	int:DPY30
Interaction	RHOV interactions	CDC42BPA MYO9A SSRP1 CDC42BPB ADCY9 LONP1 MYH14 PRORP XPOT	5.52e-06	243	106	9	int:RHOV
Interaction	NEFM interactions	CDC42BPA VWA8 SMURF1 MICU1 ABCC12 PLEC DNAH9 XPOT	7.38e-06	190	106	8	int:NEFM
Interaction	LURAP1 interactions	CDC42BPA MYO9A CDC42BPB HMG20A PPP2R5D ARRB2 NF2	8.01e-06	137	106	7	int:LURAP1
GeneFamily	Dyneins, axonemal	DNAH10 DNAH2 DNAH9	3.64e-05	17	70	3	536
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	SRGAP2 SRGAP2C SRGAP2B	9.31e-05	23	70	3	1288
GeneFamily	Septins	SEPTIN6 SEPTIN11	1.12e-03	13	70	2	732
GeneFamily	ATP binding cassette subfamily C	ABCC4 ABCC12	1.12e-03	13	70	2	807
GeneFamily	AAA ATPases	PSMC1 ATAD2 LONP1	1.13e-03	53	70	3	413
GeneFamily	DNA polymerases	POLB POLK	3.55e-03	23	70	2	535
Coexpression	BENPORATH_SOX2_TARGETS	CDC42BPA MYO9A GNPTAB ARFGEF1 NCBP1 ATAD2 KIF20B SEPTIN6 HMG20A C1orf21 FTL ARIH1 PRORP	8.52e-06	734	106	13	M3835
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	APPBP2 FOXK2 CDC42BPA CDK19 ARFGEF1 SRGAP2 NR3C1 CBLB KIF20B ADCY9 TBC1D31 MIA2 PPP3R1 ARIH1	9.22e-06	856	106	14	M4500
Coexpression	GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	ABCC4 VWA8 MISP NF2 PLCB2 PLEC XPOT	1.75e-05	200	106	7	M5185
ToppCell	droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARL2BP PDE2A NT5C3B KIF20B SEPTIN6 NPHP3	2.80e-06	165	106	6	8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KSR2 DNAH2 SHLD1 SEPTIN6 TBC1D31 CFAP57	3.32e-06	170	106	6	45de83a2231208b8e1f21061d0b91644b4a3ba93
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 CBLB SRGAP2C C1orf21 SRGAP2B DNAH9	5.08e-06	183	106	6	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 CBLB SRGAP2C C1orf21 SRGAP2B DNAH9	5.08e-06	183	106	6	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CBLB KIF20B SEPTIN6 ZC3H12D CD69 CARD11	6.11e-06	189	106	6	d05e043d0874b8563b9f5514f6c884b35c603e3a
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	6.49e-06	191	106	6	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	Control-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ABCC4 SRGAP2 SRGAP2C CD69 CARD11 SRGAP2B	6.89e-06	193	106	6	4cb938c346cc32ec122d11e6b9f25db20e0f7ff6
ToppCell	3'_v3-Lung-Lymphocytic_NK\|Lung / Manually curated celltypes from each tissue	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	6.89e-06	193	106	6	a98ee519e0da93ae4a2dcdda1ee8b4138dec131b
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	7.09e-06	194	106	6	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	IPF-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ABCC4 SRGAP2 SEPTIN6 SRGAP2C CD69 SRGAP2B	7.09e-06	194	106	6	accf4b7b09e2048f2e47a52201e0158684dda8fe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 ARRB2 ZC3H12D PLCB2 SRGAP2B TET3	7.09e-06	194	106	6	c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 ARRB2 ZC3H12D PLCB2 SRGAP2B TET3	7.52e-06	196	106	6	cbc727b55b6433a701b1a331028a49960fcee6ee
ToppCell	Influenza_Severe-NK\|Influenza_Severe / Disease group and Cell class	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	7.74e-06	197	106	6	d0f58ee4c02573d214deb210bb7efd3d6118f267
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA0513 SRGAP2 SRGAP2C ARRB2 PLCB2 SRGAP2B	7.74e-06	197	106	6	dea1d29154c585ab588e50b83c7c8de7fe24d2d4
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	7.97e-06	198	106	6	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	7.97e-06	198	106	6	90023468f3498548a92d75928f476b4157bde813
ToppCell	severe_influenza-NK\|severe_influenza / disease group, cell group and cell class (v2)	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	7.97e-06	198	106	6	d431beb870ff5e165d98febfb27049d729e37dc8
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 DNAH2 TACC2 MISP MYH14 DNAH9	8.20e-06	199	106	6	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 DNAH2 TACC2 MISP MYH14 DNAH9	8.20e-06	199	106	6	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SRGAP2 SRGAP2C ARRB2 CARD11 PLCB2 SRGAP2B	8.20e-06	199	106	6	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 DNAH2 TACC2 MISP MYH14 DNAH9	8.20e-06	199	106	6	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 DNAH2 TACC2 MISP MYH14 DNAH9	8.20e-06	199	106	6	00b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	GTPBP4 SSRP1 CTNNBL1 SMARCA4 NONO FKBP4	8.20e-06	199	106	6	6f159c1215439ec22374903124085746fa8da333
ToppCell	Mild_COVID-19-Epithelial\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH10 DNAH2 TACC2 MISP MYH14 DNAH9	8.20e-06	199	106	6	72689bda7476930887ae007682fcab27f956f050
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO9A MISP MYH14 SYTL5 CSAD SMARCA4	8.44e-06	200	106	6	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ATAD2 ADA BCAS4 SEPTIN6 SMARCA4 NONO	8.44e-06	200	106	6	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO9A MISP MYH14 SYTL5 CSAD SMARCA4	8.44e-06	200	106	6	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-NK\|Influenza_Severe / Disease, condition lineage and cell class	GNPTAB PRR5 CBLB C1orf21 CD69 CARD11	8.44e-06	200	106	6	04ac14414d550b14dc46d682e7af9dd43982211a
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ATAD2 ADA BCAS4 SEPTIN6 SMARCA4 NONO	8.44e-06	200	106	6	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR5 ZC3H12D CD69 CARD11 PLCB2	3.38e-05	154	106	5	ee03b386d28a524084eaf1c0091f7389daa34250
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR5 ZC3H12D CD69 CARD11 PLCB2	3.38e-05	154	106	5	3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB CBLB CD69 CARD11 PLCB2	3.70e-05	157	106	5	170197b76620df31495f1247f365da382b2d8045
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERCC3 FAAH2 MYH14 GYG2 CFAP57	3.70e-05	157	106	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB CBLB CD69 CARD11 PLCB2	3.70e-05	157	106	5	c21520301cc0d5d4b1cc4b8ec735f9adb698e768
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB CBLB CD69 CARD11 PLCB2	3.82e-05	158	106	5	7274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRR5 SEPTIN6 ZC3H12D CARD11 CNP	3.82e-05	158	106	5	66c011e9de002224f70725dfe8e7871c8d304492
ToppCell	Brain_organoid-organoid_Velasco_nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	SEPTIN6 PHKG1 SRGAP2C SEPTIN11 SRGAP2B	4.17e-05	161	106	5	2de213169fe1965ceaea545297228117c81d9909
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KSR2 PRR5 ZC3H12D CD69 CNP	4.43e-05	163	106	5	2a561aa4518cf52d8470eff083b84f942a2b2b5d
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh\|GI_large-bowel / Manually curated celltypes from each tissue	KSR2 ARFGEF1 NR3C1 FAAH2 CSAD	4.43e-05	163	106	5	4104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DNAH2 FTL GSG1L DNAH9 IQCM	4.97e-05	167	106	5	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY9 MISP MIA2 MYH14 SPHK1	6.90e-05	179	106	5	88dbec952507d84b85b08165eec80df99ed1e736
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY9 MISP MIA2 MYH14 SPHK1	6.90e-05	179	106	5	daf8189a22786171e2b629261cf720736aa4ebdb
ToppCell	facs-Heart-LV-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPARD SEPTIN6 ZC3H12D CD69 CARD11	7.27e-05	181	106	5	57f82f54e20e19aa17a2ea22af22e3bc8965d622
ToppCell	facs-Heart-LV-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPARD SEPTIN6 ZC3H12D CD69 CARD11	7.27e-05	181	106	5	8855812c85ef45c1be6bd511619b2dfe5e441264
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATAD2 C1orf21 MIA2 SEPTIN11 PLEC	7.47e-05	182	106	5	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	NS-critical-d_0-4-Lymphoid-Treg\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CBLB KIF20B SEPTIN6 TBC1D31 CD69	7.66e-05	183	106	5	f478dfa231fc1b12ead0183cc9d22077cdf43d1f
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR3C1 MIA2 SEPTIN11 CD69 CNP	7.86e-05	184	106	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 CBLB SRGAP2C C1orf21 SRGAP2B	7.86e-05	184	106	5	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEPTIN6 ZC3H12D CD69 CARD11 CNP	8.48e-05	187	106	5	57f9c9162694c184a8fd6634ee0fad511ca71c9e
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEPTIN6 ZC3H12D CD69 CARD11 CNP	8.48e-05	187	106	5	6ce6d3678026101c4397320430433c9f05740883
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 MYH14 CFAP57 DNAH9 IQCG	8.48e-05	187	106	5	1bba994aaaa9825b54aaeaff3829850267bc4602
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 MYH14 CFAP57 DNAH9 IQCG	8.48e-05	187	106	5	d6ac351e7aeba98851d308c14ac395044fe4fbbb
ToppCell	COPD-Lymphoid-NK\|COPD / Disease state, Lineage and Cell class	PRR5 CBLB C1orf21 CD69 CARD11	8.70e-05	188	106	5	c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	TACC2 C1orf21 CD69 CARD11 DNAH9	8.70e-05	188	106	5	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	ASK440-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	ABCC4 GNPTAB SEPTIN6 CTNNBL1 CD69	8.92e-05	189	106	5	72a19b20cb0f7283afe5f85d62a21cff69fd78d0
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 MYH14 CFAP57 DNAH9 IQCG	8.92e-05	189	106	5	a28e0922e10013ae79266f6a3f9305e6ee614d8b
ToppCell	COPD-Lymphoid-NK\|World / Disease state, Lineage and Cell class	PRR5 CBLB C1orf21 CD69 CARD11	8.92e-05	189	106	5	c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell	IPF-Lymphoid-NK\|IPF / Disease state, Lineage and Cell class	PRR5 CBLB C1orf21 CD69 CARD11	8.92e-05	189	106	5	d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCC4 CDC42BPA DNAJC6 CTNNBL1 SEPTIN11	8.92e-05	189	106	5	56156325cc36b1329bf483f81bb74f371ef15e20
ToppCell	Control-Lymphoid-NK\|World / Disease state, Lineage and Cell class	PRR5 CBLB C1orf21 CD69 CARD11	8.92e-05	189	106	5	89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD1A ASTE1 SEPTIN6 HMG20A CD69	9.14e-05	190	106	5	373629dde5eda722424c5e6087763f0c5db67cf4
ToppCell	Control-Myeloid-cDC2\|Control / Disease state, Lineage and Cell class	SRGAP2 PPARD SEPTIN6 SRGAP2C SRGAP2B	9.14e-05	190	106	5	4e481e42353d47af7991744000403af2873f6a41
ToppCell	Control-Lymphoid-NK\|Control / Disease state, Lineage and Cell class	PRR5 CBLB C1orf21 CD69 CARD11	9.14e-05	190	106	5	f7bd8521a40ac30a64dc439f17e2f6c7d021ef65
ToppCell	Control-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	SRGAP2 PPARD SEPTIN6 SRGAP2C SRGAP2B	9.37e-05	191	106	5	11dfd8f38beb294f42710cfbd355cb089e1023c0
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	SRGAP2 SRGAP2C ARRB2 SRGAP2B TET3	9.37e-05	191	106	5	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CBLB SEPTIN6 ZC3H12D CD69 CARD11	9.37e-05	191	106	5	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 DNAH2 TACC2 MYH14 DNAH9	9.37e-05	191	106	5	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CBLB SEPTIN6 ZC3H12D CD69 CARD11	9.37e-05	191	106	5	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH10 DNAH2 MYH14 CFAP57 DNAH9	9.37e-05	191	106	5	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	IPF-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	ABCC4 SRGAP2 SEPTIN6 SRGAP2C SRGAP2B	9.37e-05	191	106	5	9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 DNAH2 TACC2 MYH14 DNAH9	9.37e-05	191	106	5	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 DNAH2 TACC2 MYH14 DNAH9	9.37e-05	191	106	5	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	SRGAP2 PPARD SEPTIN6 SRGAP2C SRGAP2B	9.37e-05	191	106	5	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CBLB SEPTIN6 ZC3H12D CD69 CARD11	9.37e-05	191	106	5	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH10 DNAH2 MYH14 CFAP57 DNAH9	9.37e-05	191	106	5	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ABCC4 SRGAP2 SEPTIN6 SRGAP2C SRGAP2B	9.60e-05	192	106	5	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 ARRB2 CARD11 PLCB2 SRGAP2B	9.60e-05	192	106	5	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	SRGAP2 SRGAP2C ARRB2 SRGAP2B TET3	9.60e-05	192	106	5	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ARFGEF1 CBLB FAAH2 ZC3H12D ARIH1	9.60e-05	192	106	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 ARRB2 CARD11 PLCB2 SRGAP2B	9.60e-05	192	106	5	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KIAA0513 MYO9A KSR2 CPLX1 PPP3R1	9.60e-05	192	106	5	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	Ciliated-cil-3\|World / Class top	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	9.60e-05	192	106	5	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	multiciliated\|World / shred by cell class for turbinate	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	9.60e-05	192	106	5	0f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCell	IPF-Myeloid-cDC2\|IPF / Disease state, Lineage and Cell class	ABCC4 SRGAP2 SEPTIN6 SRGAP2C SRGAP2B	9.60e-05	192	106	5	fe1de692fec48cba4a9bbc6eaa257260e8b4e800
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SMURF1 PPARD FTL ARIH1 FKBP4	9.60e-05	192	106	5	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	POLB NR3C1 ADA SEPTIN6 CARD11	9.84e-05	193	106	5	30abf991ac17c18679ab7d633e7549c0ce841920
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SRGAP2 ARRB2 CARD11 PLCB2 SRGAP2B	9.84e-05	193	106	5	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	CF-Lymphoid\|CF / Disease state, Lineage and Cell class	CBLB BCAS4 ZC3H12D CD69 CARD11	9.84e-05	193	106	5	11de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SRGAP2 PPARD SEPTIN6 SRGAP2C SRGAP2B	1.01e-04	194	106	5	bde6830a281f7cd7fd1733e40a41ddd2673ba88e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.01e-04	194	106	5	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CBLB KIF20B SEPTIN6 CD69 CARD11	1.03e-04	195	106	5	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMC1 DNAJC21 SSRP1 SEPTIN6 NONO	1.03e-04	195	106	5	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 DNAH2 CFAP57 DNAH9 IQCG	1.03e-04	195	106	5	e7f069f557a59ee7b502ff82ad4c9f47fa619ba8
ToppCell	Lung_Parenchyma-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BCAS4 SEPTIN6 ZC3H12D CD69 CARD11	1.06e-04	196	106	5	279f113916dcb398111d787ae06bcf20ff8febd2
ToppCell	Parenchyma_Control_(B.)-Immune-TX-B_cells\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	BCAS4 SEPTIN6 ZC3H12D CD69 CARD11	1.06e-04	196	106	5	a2759691606b03de9d67e8d38487915cd4e7d448
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A	ABCC4 CDC42BPA PPARD NR3C1 DNAJC6 NF2 SPHK1 SEPTIN11	3.57e-06	196	105	8	6994_DN
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; HL60; HT_HG-U133A	SETD1A SZT2 PENK ADAM22 NF2 MYH14 SEPTIN11 PLEC	3.85e-06	198	105	8	2910_UP
Drug	2'-deoxyadenosine	POLB ADA POLK	7.85e-06	9	105	3	ctd:C058118
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	GTPBP4 CDC42BPA NR3C1 NEB ADCY9 PPP2R5D MYH14	3.19e-05	193	105	7	5986_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	GNPTAB CDK19 ADAM22 PPP3R1 NF2 GYG2 IQCG	3.29e-05	194	105	7	6066_DN
Drug	Adrenocorticotropic Hormone	NR3C1 ADA CNP	3.34e-05	14	105	3	ctd:D000324
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CDC42BPA ARRB2 NF2 CTNNBL1 SMARCA4 SEPTIN11 GYG2	3.52e-05	196	105	7	1678_DN
Drug	Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; PC3; HT_HG-U133A	GTPBP4 CDK19 ARFGEF2 NR3C1 ADA SEPTIN6 PPP3R1	3.52e-05	196	105	7	7297_DN
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	ARFGEF1 DNAJC6 ADAM22 PPP2R5D MIA2 NF2 SEPTIN11	3.52e-05	196	105	7	3448_DN
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CDC42BPA SZT2 PENK PRR5 PPARD NEB ADAM22	3.52e-05	196	105	7	6000_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	GTPBP4 NR3C1 NEB ADCY9 MIA2 PPP3R1 SEPTIN11	3.63e-05	197	105	7	5843_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	CDC42BPA SZT2 GNPTAB NR3C1 MIA2 NF2 IQCG	3.63e-05	197	105	7	3426_UP
Drug	Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A	SMURF1 NCBP1 ADAM22 MIA2 PPP3R1 SEPTIN11 IQCG	3.75e-05	198	105	7	3367_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	SETD1A NCBP1 TACC2 NEB SEPTIN6 NF2 IQCG	3.75e-05	198	105	7	4090_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	PRR5 NEB ADAM22 MIA2 SMARCA4 GYG2 PLEC	3.75e-05	198	105	7	5393_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	VWA8 CDK19 SMURF1 NCBP1 ADAM22 ARRB2 PPP3R1	3.75e-05	198	105	7	1503_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	FOXK2 CDC42BPA SZT2 NR3C1 ADAM22 ADAMTS12 PPP3R1	3.87e-05	199	105	7	3287_UP
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A	SZT2 PENK PPARD ADCY9 HMG20A PPP3R1 SEPTIN11	3.87e-05	199	105	7	2713_DN
Drug	Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ABCC4 CDC42BPA ARFGEF1 TACC2 DNAJC6 PPP3R1 SPHK1	3.87e-05	199	105	7	6249_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	SETD1A CDC42BPA PRR5 SMURF1 MIA2 PPP3R1 NF2	3.87e-05	199	105	7	5575_DN
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; HL60; HT_HG-U133A	KIAA0513 GNPTAB DNAH2 SMURF1 ADAM22 MISP SEPTIN11	4.00e-05	200	105	7	2503_UP
Drug	methyl methanesulfonate	ERCC3 POLB ARFGEF1 ADA NF2 SMARCA4 ARIH1 POLK XPOT	4.82e-05	364	105	9	CID000004156
Drug	EHNA	PDE2A NT5C3B ADA CARD11 DNAH9	5.19e-05	87	105	5	CID000003206
Drug	K-Cl	MYO9A POLB PENK KSR2 NR3C1 ADCY9 MYH14 ACTR6 CSAD CARD11 POLK	6.24e-05	567	105	11	CID000004873
Drug	17alpha-estradiol	ABCC4 POLB PENK GRIA1 PPARD NR3C1 ATAD2 ADCY9 ACTR6 SMARCA4 CD69 CARD11 FTL PLCB2 PLEC POLK FKBP4	9.33e-05	1303	105	17	CID000000450
Drug	NSC615828	POLB PPARD ADA POLK	1.05e-04	53	105	4	CID000002235
Drug	istradefylline	PENK GRIA1	1.26e-04	4	105	2	ctd:C111599
Drug	ANA 2000	NR3C1 ARIH1	1.26e-04	4	105	2	CID006336581
Drug	N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine	POLB POLK	1.26e-04	4	105	2	ctd:C000598755
Drug	9-beta-D-arabinofuranosylguanine	GTPBP4 PDE2A POLB SMURF1 ARFGEF2 ARFGEF1 NCBP1 ADA ADCY9 ACTR6 CARD11 PLCB2 POLK	1.35e-04	843	105	13	CID000000765
Drug	L-685-818	ARFGEF2 ARFGEF1 PPP3R1	1.38e-04	22	105	3	CID000003850
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIAA0513 PPARD DNAJC6 SEPTIN6 GYG2 IQCG	1.57e-04	174	105	6	5572_UP
Drug	5-hydroxymethylcytosine	FTL TET3	2.09e-04	5	105	2	ctd:C011865
Drug	IEM 1460	PENK GRIA1	2.09e-04	5	105	2	ctd:C110702
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A	SETD1A CDC42BPA PPARD NEB CD69 PLCB2	2.26e-04	186	105	6	2426_DN
Drug	AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A	ARFGEF1 ADA PPP2R5D PPP3R1 FTL PLEC	2.46e-04	189	105	6	6920_DN
Drug	geldanamycin; Up 200; 1uM; MCF7; HG-U133A	SMURF1 TACC2 PPARD NR3C1 ADAM22 PHKG1	2.46e-04	189	105	6	611_UP
Drug	trimethoprim-sulfamethoxazole	ERCC3 GRIA1 CSAD ARIH1	2.47e-04	66	105	4	CID000358641
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A	GTPBP4 PPARD NEB ADAM22 PPP3R1 NF2	2.53e-04	190	105	6	4421_DN
Drug	NSC226080	CDC42BPA PENK PRR5 NCBP1 PPARD NR3C1 PPP2R5D PPP3R1 MYH14 ACTR6 FKBP4 XPOT	2.60e-04	782	105	12	CID000005040
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A	VWA8 ADA ARRB2 SMARCA4 SEPTIN11 PLEC	2.61e-04	191	105	6	4647_DN
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	SETD1A PRR5 ADCY9 MYH14 PLCB2 PLEC	2.68e-04	192	105	6	4462_DN
Drug	C75; Down 200; 10uM; MCF7; HT_HG-U133A	CDC42BPA NR3C1 ADAM22 PPP2R5D NF2 DNAH9	2.68e-04	192	105	6	6423_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	VWA8 ARFGEF1 NR3C1 NEB PPP2R5D PPP3R1	2.68e-04	192	105	6	5509_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A	PPP2R5D ARRB2 PPP3R1 NF2 SEPTIN11 PLEC	2.68e-04	192	105	6	5959_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; HL60; HT_HG-U133A	APPBP2 ERCC3 GNPTAB CDK19 MIA2 NF2	2.76e-04	193	105	6	2561_DN
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; HL60; HG-U133A	GTPBP4 GNPTAB ADA PPP3R1 SMARCA4 SEPTIN11	2.76e-04	193	105	6	1550_DN
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SETD1A ABCC4 CDC42BPA ASTE1 ADCY9 SEPTIN11	2.83e-04	194	105	6	7468_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	NR3C1 NEB ADAM22 MIA2 PPP3R1 MYH14	2.83e-04	194	105	6	4424_DN
Drug	Rp-cAMPS	PDE2A GRIA1 ADCY9 ACTR6 CARD11 NONO	2.83e-04	194	105	6	CID006426631
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	ARFGEF2 ADA PPP2R5D ARRB2 PPP3R1 NF2	2.83e-04	194	105	6	2086_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	ABCC4 KIAA0513 NR3C1 PPP3R1 PHF20L1 MYH14	2.83e-04	194	105	6	990_DN
Drug	NSC406942	POLB GNPTAB GRIA1 NT5C3B NR3C1 ADCY9 ACTR6 PLCB2 DNAH9 CNP	2.86e-04	565	105	10	CID000001115
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	CDC42BPA CDK19 PRR5 SMURF1 PPP3R1 IQCG	2.91e-04	195	105	6	6834_DN
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A	ARFGEF1 NEB PPP2R5D MIA2 PPP3R1 NF2	2.91e-04	195	105	6	5520_DN
Drug	Dimethadione [695-53-4]; Down 200; 31uM; PC3; HT_HG-U133A	SMURF1 NR3C1 ADA PPP2R5D PPP3R1 SEPTIN11	2.91e-04	195	105	6	4607_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	CDC42BPA MYO9A ARFGEF1 ADAM22 NF2 CNP	2.91e-04	195	105	6	5004_DN
Drug	DL-PPMP; Down 200; 2uM; MCF7; HT_HG-U133A_EA	CDC42BPA KIAA0513 VWA8 CDK19 SMURF1 PPP3R1	2.91e-04	195	105	6	1121_DN
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	KIAA0513 SMURF1 ARFGEF1 NCBP1 NF2 CTNNBL1	2.91e-04	195	105	6	5329_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SETD1A SMURF1 NR3C1 ADAM22 SEPTIN11 GYG2	2.91e-04	195	105	6	2241_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A	CBLB ARRB2 MIA2 PPP3R1 MYH14 SMARCA4	2.91e-04	195	105	6	5313_DN
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; MCF7; HT_HG-U133A	GTPBP4 SMURF1 NCBP1 NEB MIA2 NF2	2.91e-04	195	105	6	3179_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	KIAA0513 CDC42BPB SEPTIN6 PPP2R5D MIA2 NF2	2.99e-04	196	105	6	1794_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; HL60; HT_HG-U133A	SETD1A CDC42BPA CDK19 NCBP1 NF2 PLCB2	2.99e-04	196	105	6	1289_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	APPBP2 FOXK2 MYO9A ADAMTS12 PPP3R1 SMARCA4	2.99e-04	196	105	6	2005_DN
Drug	5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA	CDC42BPA MYO9A ADAM22 MIA2 MYH14 PLEC	2.99e-04	196	105	6	960_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	NCBP1 ARRB2 PPP3R1 NF2 SEPTIN11 CNP	2.99e-04	196	105	6	5679_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A	VWA8 PPARD HMG20A NF2 MYH14 SEPTIN11	2.99e-04	196	105	6	5751_DN
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	ASTE1 ARFGEF1 NR3C1 SEPTIN6 PLCB2 PLEC	2.99e-04	196	105	6	1174_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; HL60; HG-U133A	GTPBP4 ARL2BP ABCC4 ARFGEF1 NCBP1 SRGAP2	2.99e-04	196	105	6	1993_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	SETD1A SMURF1 ARFGEF2 PPARD ARRB2 PPP3R1	2.99e-04	196	105	6	6559_UP
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CDC42BPA CDK19 PPP2R5D MIA2 NF2 PLEC	2.99e-04	196	105	6	1685_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A	VWA8 NEB ADA MIA2 NF2 PLEC	3.08e-04	197	105	6	2559_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A	NCBP1 TBC1D31 PPP3R1 NF2 MYH14 PLCB2	3.08e-04	197	105	6	1368_DN
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A	KIAA0513 PPARD NR3C1 ARRB2 PPP3R1 PLEC	3.08e-04	197	105	6	4604_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	NEB ADAM22 MIA2 PPP3R1 NF2 GYG2	3.08e-04	197	105	6	3355_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	CDK19 ARRB2 PHF20L1 NF2 SMARCA4 SEPTIN11	3.08e-04	197	105	6	2306_DN
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A	CDK19 SRGAP2 SEPTIN6 MISP ARRB2 PPP3R1	3.08e-04	197	105	6	2022_UP
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	KIAA0513 SZT2 PPP3R1 SMARCA4 SEPTIN11 PLEC	3.08e-04	197	105	6	4606_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	GTPBP4 ADAM22 HMG20A PPP3R1 SEPTIN11 IQCG	3.08e-04	197	105	6	3364_DN
Drug	0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A	CDC42BPA SZT2 VWA8 PENK SRGAP2 NF2	3.08e-04	197	105	6	7069_DN
Drug	Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	CDK19 PRR5 ADAM22 C1orf21 PPP3R1 MYH14	3.08e-04	197	105	6	6010_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A	CDC42BPA GNPTAB PENK ADAM22 NF2 IQCG	3.08e-04	197	105	6	3525_UP
Drug	Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A	GTPBP4 SMURF1 NCBP1 ADAM22 PPP3R1 SEPTIN11	3.08e-04	197	105	6	3372_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A	NR3C1 ADCY9 MISP PPP2R5D NF2 SMARCA4	3.08e-04	197	105	6	7206_DN
Drug	PR toxin	POLB ARIH1	3.12e-04	6	105	2	CID000440907
Drug	9-(2-hydroxy-3-nonyl)adenine	PDE2A ADA	3.12e-04	6	105	2	ctd:C010192
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A	APPBP2 ERCC3 HMG20A PPP3R1 PHF20L1 PLCB2	3.16e-04	198	105	6	1997_DN
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	GTPBP4 GNPTAB SMURF1 ADAM22 MIA2 GYG2	3.16e-04	198	105	6	6073_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A	CDK19 SMURF1 MIA2 PPP3R1 NF2 SEPTIN11	3.16e-04	198	105	6	3449_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A	GTPBP4 ABCC4 SMURF1 PPP3R1 PHF20L1 NF2	3.16e-04	198	105	6	5995_DN
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; HL60; HT_HG-U133A	CDC42BPA GRIA1 DNAJC6 MYH14 GYG2 CCDC70	3.16e-04	198	105	6	3010_UP
Drug	Omeprazole [73590-58-6]; Down 200; 11.6uM; PC3; HT_HG-U133A	GTPBP4 ADA SEPTIN6 ARRB2 NF2 SEPTIN11	3.16e-04	198	105	6	6606_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A	CDC42BPA SZT2 CDK19 PPARD ADA SEPTIN11	3.16e-04	198	105	6	7310_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CDC42BPA CDK19 NR3C1 CDC42BPB ARRB2 CTNNBL1	3.16e-04	198	105	6	1689_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CDC42BPA PENK NEB ADAMTS12 NF2 MYH14	3.16e-04	198	105	6	1476_UP
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; HL60; HT_HG-U133A	CDC42BPA PENK SMURF1 DNAJC6 ADAM22 NF2	3.16e-04	198	105	6	2909_UP
Drug	Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A	CDC42BPA ARFGEF2 PPARD NR3C1 MYH14 PLEC	3.16e-04	198	105	6	6206_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SETD1A NEB C1orf21 PPP3R1 PHF20L1 PLEC	3.16e-04	198	105	6	7011_UP
Drug	Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; HL60; HT_HG-U133A	CDK19 SMURF1 MIA2 NF2 MYH14 CD69	3.16e-04	198	105	6	3130_DN
Disease	Movement Disorders	MICU1 FTL TET3	1.37e-04	29	102	3	C0026650
Disease	Schizoaffective Disorder	CPLX1 GRIA1 NR3C1	1.37e-04	29	102	3	C0036337
Disease	multiple sclerosis	SETD1A VWA8 NR3C1 CBLB PHKG1 SMARCA4 CD69 CARD11 PLEC	2.22e-04	594	102	9	MONDO_0005301
Disease	protein S measurement	DNAJC6 HMG20A	2.46e-04	7	102	2	EFO_0004637
Disease	NEPHRONOPHTHISIS 2	NPHP3 TTC21B	3.27e-04	8	102	2	C1865872
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCC12	4.19e-04	9	102	2	DOID:1485 (implicated_via_orthology)
Disease	Depressive disorder	PENK CPLX1 GRIA1 NR3C1 ARRB2 FTL	5.14e-04	289	102	6	C0011581
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPA CDC42BPB	6.38e-04	11	102	2	DOID:0060669 (implicated_via_orthology)
Disease	Cocaine-Related Disorders	SMURF1 GRIA1 NR3C1 SMARCA4	7.40e-04	117	102	4	C0236736
Disease	xanthine measurement	KSR2 ADAM22	9.00e-04	13	102	2	EFO_0010548
Disease	Nephronophthisis	NPHP3 TTC21B	9.00e-04	13	102	2	C0687120
Disease	Cocaine Abuse	SMURF1 GRIA1 NR3C1 SMARCA4	1.00e-03	127	102	4	C0009171
Disease	Psychosis, Brief Reactive	CPLX1 NR3C1	1.05e-03	14	102	2	C0033958
Disease	Schizophreniform Disorders	CPLX1 NR3C1	1.05e-03	14	102	2	C0036358
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant	DDX12P ZC3H12D	1.38e-03	16	102	2	EFO_0004276, EFO_0004775, GO_0036277
Disease	Cocaine Dependence	SMURF1 GRIA1 NR3C1 SMARCA4	1.40e-03	139	102	4	C0600427
Disease	alpha-L-iduronidase measurement	GNPTAB CPLX1	1.56e-03	17	102	2	EFO_0020139
Disease	Mental Depression	PENK CPLX1 GRIA1 NR3C1 ARRB2	1.92e-03	254	102	5	C0011570
Disease	emphysema pattern measurement	VWA8 SEPTIN11	1.95e-03	19	102	2	EFO_0005850
Disease	epilepsy (biomarker_via_orthology)	GRIA1 NF2	2.38e-03	21	102	2	DOID:1826 (biomarker_via_orthology)
Disease	Drug toxicity	ABCC4 NR3C1 ABCC12	3.12e-03	84	102	3	C0013221
Disease	Adverse reaction to drug	ABCC4 NR3C1 ABCC12	3.12e-03	84	102	3	C0041755

Protein segments in the cluster

Peptide	Gene	Start	Entry
KAREYIDRMIKISDG	TTC21B	126	Q7Z4L5
FYRDMDIAKLKGEEN	ACTR6	216	Q9GZN1
GFLNDKVEERRERYM	NT5C3B	251	Q969T7
RIAYEFVEMKAKEGV	ADA	81	P00813
MDYDFKAKLAAERER	CDK19	1	Q9BWU1
EKVDRLMELHFKYLG	CTNNBL1	436	Q8WYA6
KIDRLMEKFAARYLE	ARFGEF1	796	Q9Y6D6
KRERDLELEMGDDYI	GTPBP4	396	Q9BZE4
IDPEAIKYFRERMEK	GSG1L	266	Q6UXU4
IKYFRERMEKRDGSE	GSG1L	271	Q6UXU4
KIDRLMEKFAARYIE	ARFGEF2	741	Q9Y6D5
EFMKYRRDFIKEKSD	ADAM22	311	Q9P0K1
FKEVKRAGLNEMVEY	PPP2R5D	141	Q14738
GRLYQSMRKFKEAEE	APPBP2	436	Q92624
NFRKDELKGIYKDRM	ATAD2	391	Q6PL18
FREEMKIFREKIEDF	CCDC70	51	Q6NSX1
KLRFAFRIYDMDKDG	PPP3R1	91	P63098
FKEMFLDYRAEKEGR	ARL2BP	121	Q9Y2Y0
FARLRLKGMKDDDYD	ARRB2	391	P32121
EDGAKMLYAEFQRVK	ASTE1	511	Q2TB18
VFQYDRKGDLEKLMA	ADAMTS12	771	P58397
KMHFYDIIAREEKGR	IQCG	206	Q9H095
DRKKFYEIMFAKRED	IQCM	361	A0A1B0GVH7
RIEKEELDMKGSGFY	NUDCD1	186	Q96RS6
ETLALRDFMRGYVEK	KIAA0513	91	O60268
KKLRELEGYDKYMER	LRRC57	216	Q8N9N7
DEAKELQKRYGGFMR	PENK	201	P01210
DKEKLMERYFDGNLE	ARIH1	141	Q9Y4X5
EKDMNFLKRYAGREE	CD69	126	Q07108
LRPEDGEDKEMKTYR	MISP	111	Q8IVT2
TEEEMRKLFEKYGKA	NONO	86	Q15233
GKELYEKKDAEMDRI	NCBP1	181	Q09161
KDKNKYRFEIMGEEE	GNPTAB	1106	Q3T906
AVARLEGREFEYLMK	FOXK2	36	Q01167
EGREFEYLMKKRSVT	FOXK2	41	Q01167
ADRDKERYMKELEQY	HMG20A	156	Q9NP66
AEEKREGYERLLKMQ	FTL	56	P02792
LFEKMEEKDFYRESR	CFAP57	306	Q96MR6
EDQLKAFKREVMAYR	KSR2	701	Q6VAB6
RELERKFVKDFQDYM	DYNC1LI2	171	O43237
AIRLFKEGKERMYEE	CBLB	121	Q13191
KYAKMEAEREAVRQG	CPLX1	51	O14810
KKRSGFRDRKVMEYE	MICU1	101	Q9BPX6
EAIVEMYRGKKRHEV	MYH14	156	Q7Z406
IFKDLQKMAEVGYDR	PDE2A	776	O00408
NKEMKKYAEDRERFF	KIF20B	1481	Q96Q89
EGEIKYFIDKQMLRD	L1RE1	291	Q9UN81
HYGMEDVKKRILEFI	LONP1	491	P36776
FDEIRMTYIKELGKA	NR3C1	686	P04150
GTIKDKYERERAMLF	CDC42BPB	756	Q9Y5S2
KYERERAMLFDENKK	CDC42BPB	761	Q9Y5S2
KELQEMEARYEKEFG	DNAJC21	266	Q5F1R6
RGRARDEAEMEYLKI	NF2	196	P35240
FKIGHKRRLEEDDMY	ABCC4	31	O15439
IDYMGKDAFARIQEK	GYG2	481	O15488
AFISEEEIAKYMKRG	CHAMP1	691	Q96JM3
FERMKEYRVQDGKIF	DNAJC6	271	O75061
RMLDEKIEKGRDYCS	C1orf21	101	Q9H246
KKEDFMAELYRVLEA	DDX12P	41	Q92771
DRYEMEDGKVIERLG	ADCY9	541	O60503
EPREKMDLVTYFGKR	CNP	231	P09543
EMRGIYAKVDRLEAF	BCAS4	106	Q8TDM0
YAKVDRLEAFVKMVG	BCAS4	111	Q8TDM0
VLARYLVEEMKKREG	CSAD	386	Q9Y600
NGIVKYRFEEAMKEA	FAAH2	86	Q6GMR7
RMTYALRDFVEEKLG	DNAH9	3861	Q9NYC9
GRVLRAKKGMVAEEY	ERCC3	641	P19447
REKKLYANMFERLAE	FKBP4	406	Q02790
TEEGYRMLFQDLEKK	GRIA1	181	P42261
EDGRMKFDEYIKRLA	DNAH10	2356	Q8IVF4
DYNKFRAGIKDLEVM	DNAH2	456	Q9P225
KYFGDFEKRIPREEM	POLB	141	P06746
EGYRKLVKDMEDGLI	CARD11	756	Q9BXL7
SRIEKIDYEEGKMLV	PHF20L1	31	A8MW92
LMKRGELFDYLTEKV	PHKG1	106	Q16816
GFAYAKEDKIMLDDR	MIA2	386	Q96PC5
HEKEMILGVLKRDEY	SYTL5	16	Q8TDW5
EEAGQVFLLMKKDYR	SZT2	11	Q5T011
DDEIGRKVYMRDREI	TBC1D31	796	Q96DN5
LYRRCKLEEMGFKDT	SEPTIN11	296	Q9NVA2
GFFRRTIRMKLEYEK	PPARD	96	Q03181
DFEKAAELYKRAMEI	NPHP3	1276	Q7Z494
MVILRDKIRFYEGQK	PRR5	96	P85299
MAEDEEGYRKLIDQK	SMARCA4	531	P51532
EDDGLRKSLDRFYEM	SHLD1	91	Q8IYI0
DFFRKKAEIEMDYSR	SRGAP2C	51	P0DJJ0
DFFRKKAEIEMDYSR	SRGAP2B	51	P0DMP2
ERIKDYLLMEEEFIR	PSMC1	66	P62191
KELMEERGRYAKLIH	ABCC12	686	Q96J65
KIMRDVIDGGDQYRK	PRORP	371	O15091
IRLIYFKNKMAEGDE	CDC42BPA	1506	Q5VT25
RETFLKDMCRKYGEV	SETD1A	106	O15047
ELYRRCKLEEMGFKD	SEPTIN6	296	Q14141
KRLMVKFRGEEGLDY	SMURF1	426	Q9HCE7
AYLERMKEEGKIREE	SSRP1	451	Q08945
EDARRDYEKAMKEYE	SSRP1	601	Q08945
DFFRKKAEIEMDYSR	SRGAP2	51	O75044
EDKRRYFIKMGSSVE	POLK	216	Q9UBT6
FRRYEKMKEVLEGFR	TACC2	2836	O95359
MDRGEKIQLKRVFGY	SLC7A13	1	Q8TCU3
YEVLFREGVMVAKKD	PLEC	16	Q15149
RELMEERYGEKGKAI	TET3	856	O43151
KEALAEYEARMKGLE	PLCB2	1121	Q00722
EYEARMKGLEAEVKE	PLCB2	1126	Q00722
KMEFFQKLGYDREDV	ZC3H12D	6	A2A288
GYKLKLEEDMEYLRE	TRIM17	141	Q9Y577
EDEAMFVEYRKQLKL	XPOT	396	O43592
DVDLESEKYRRLGEM	SPHK1	176	Q9NYA1
EDGRFLMSAERYDKL	VWA8	201	A3KMH1
KIEKMRAEDGENYDI	TBCA	36	O75347
KQKDYDFEERMKELR	ZMAT2	136	Q96NC0
YEEFLRAMGLQERKE	MYO9A	2151	B2RTY4
GLEEAKRKGYDMRVD	NEB	2761	P20929